Lower Airway & Bronchial Tree Anatomy

Quick Answer

Lower Airway Anatomy encompasses the respiratory tract from the trachea to the alveoli, representing the critical gas-conducting and gas-exchanging structures of the lung.

Key Structures (Proximal to Distal):

• Trachea: 10-12 cm long, 2-2.5 cm diameter, 16-20 C-shaped cartilaginous rings, trachealis muscle posteriorly
• Carina: Bifurcation at T4-5 vertebral level; RMB angle 25 degrees, LMB angle 45 degrees
• Main Bronchi: Right (shorter, wider, more vertical), Left (longer, narrower, more horizontal)
• Lobar Bronchi: 3 right (upper, middle, lower), 2 left (upper, lower)
• Segmental Bronchi: 10 right, 8-10 left bronchopulmonary segments
• Bronchioles: Conducting (terminal) and respiratory bronchioles
• Alveoli: ~300 million, surface area 70-100 m², Type I and II pneumocytes

ICU Relevance:

• ETT positioning (tip 3-5 cm above carina)
• Bronchoscopy landmarks and anatomy
• One-lung ventilation (endobronchial tube placement)
• Aspiration patterns (RMB predominance)
• Understanding of dead space and V/Q matching

Exam Focus:

• Weibel airway generations (0-23)
• Dimensions and relations of trachea
• Blood-gas barrier structure (0.2-0.5 micrometers)
• Type I vs Type II pneumocytes
• Pulmonary vs bronchial circulation
• Applied anatomy for intubation and bronchoscopy

---

CICM First Part Exam Focus

What Examiners Expect

Written SAQ:

Common question stems:

• "Describe the anatomy of the trachea, including its dimensions, structure, blood supply, and relations" (10 marks)
• "Draw and label a diagram of the bronchial tree to the level of segmental bronchi" (8 marks)
• "Describe the structure of the alveolus and the blood-gas barrier" (10 marks)
• "Compare and contrast the right and left main bronchi and their clinical significance" (6 marks)
• "Describe the Weibel model of airway generations" (8 marks)
• "Outline the blood supply to the lung parenchyma and airways" (8 marks)

Expected depth:

• Precise dimensions (with normal ranges)
• Clear diagrams with accurate labeling
• Understanding of clinical relevance to ICU practice
• Knowledge of developmental and structural variations
• Integration with respiratory physiology concepts

Written MCQ:

Common topics tested:

• Dimensions of trachea and main bronchi
• Level of carina (vertebral and sternal references)
• Weibel generation numbers
• Bronchopulmonary segment numbers
• Type I vs Type II pneumocyte functions
• Surfactant composition and function
• Blood supply (pulmonary vs bronchial)
• ETT positioning landmarks

Oral Viva:

Expected discussion flow:

1. Overview - Define lower airway, list structures
2. Trachea - Dimensions, structure, relations, blood supply
3. Bifurcation - Carina level, bronchial angles
4. Bronchial tree - Generations, nomenclature
5. Airways - Wall structure changes along generations
6. Alveoli - Structure, cell types, blood-gas barrier
7. Blood supply - Pulmonary vs bronchial, anastomoses
8. Applied anatomy - Bronchoscopy, ETT, one-lung ventilation

Common viva scenarios:

• "Describe the anatomy you would see during bronchoscopy from the vocal cords to the segmental bronchi"
• "You are inserting a left-sided double-lumen tube. Describe the relevant anatomy"
• "A patient has a right lower lobe collapse. Describe the anatomical basis for this pattern"

Pass vs Fail Performance

Pass Standard:

• Accurate dimensions of major structures
• Correct description of carinal anatomy and bronchial angles
• Understanding of Weibel generations concept
• Knowledge of alveolar structure and pneumocyte types
• Ability to relate anatomy to clinical procedures

Common Reasons for Failure:

• Incorrect dimensions (especially tracheal length/diameter)
• Confusion of right and left bronchial angles
• Failure to identify bronchopulmonary segments
• Unable to describe blood-gas barrier structure
• No understanding of dual blood supply
• Poor quality diagrams

---

Key Points

10 Must-Know Facts

1. Trachea is 10-12 cm long (15 cm from incisors) with internal diameter of 2-2.5 cm in adults; supported by 16-20 C-shaped hyaline cartilage rings with posterior trachealis muscle [1,2]

2. Carina is located at T4-5 vertebral level (sternal angle/angle of Louis); moves 1-2 cm with respiration and neck position changes [3,4]

3. Right main bronchus is shorter (2.5 cm vs 5 cm), wider (12-16 mm vs 10-12 mm), and more vertical (25 degrees vs 45 degrees from midline), explaining higher incidence of right-sided aspiration and endobronchial intubation [5,6]

4. Weibel model describes 24 generations (0-23) of airways: trachea (Gen 0), main bronchi (Gen 1), lobar bronchi (Gen 2-3), segmental bronchi (Gen 3-4), terminal bronchioles (Gen 16), respiratory bronchioles (Gen 17-19), alveolar ducts (Gen 20-22), alveolar sacs (Gen 23) [7,8]

5. Conducting zone (Gen 0-16) provides no gas exchange (anatomical dead space ~150 mL); respiratory zone (Gen 17-23) comprises ~3,000 mL volume for gas exchange [9,10]

6. Bronchial wall transition: Cartilage rings become plates (lobar), then irregular fragments (segmental), then absent beyond 1 mm diameter bronchioles; smooth muscle increases proportionally [11,12]

7. Alveoli number approximately 300 million with total surface area of 70-100 m² (tennis court); Type I pneumocytes (95% surface area, gas exchange), Type II pneumocytes (surfactant production, regeneration) [13,14]

8. Blood-gas barrier is 0.2-0.5 micrometers thick, comprising alveolar epithelium, fused basement membranes, and capillary endothelium; enables efficient gas diffusion [15,16]

9. Dual blood supply: Pulmonary circulation (deoxygenated blood for gas exchange, ~5 L/min); Bronchial circulation (oxygenated blood from aorta for airway nutrition, 1-2% cardiac output); anastomoses contribute to physiological shunt [17,18]

10. ETT positioning: Tip should be 3-5 cm above carina (T5-T7 on CXR at mid-clavicle level); optimal depth = (height in cm/10) + 5 cm for oral tubes; flexion moves ETT 2-3 cm distally, extension moves 2 cm proximally [19,20]

---

Trachea

Macroscopic Anatomy

Definition and Extent: The trachea is a cartilaginous and membranous tube extending from the inferior border of the cricoid cartilage (C6 vertebral level) to the carina (T4-5 vertebral level), where it bifurcates into the right and left main bronchi [1,2].

Dimensions (Adults):

• Length: 10-12 cm (cervical portion ~5 cm, intrathoracic portion ~5-7 cm)
• Distance from incisors: 15 cm to carina in adult male
• External diameter: 2.3-2.7 cm (males), 2.0-2.4 cm (females)
• Internal diameter: 1.8-2.5 cm (varies with age, sex, and body size)
• Cross-sectional area: ~3-4 cm² at rest; decreases to 1 cm² at vocal cords [2,3]

Clinical Relevance: The adult tracheal diameter typically accommodates ETT sizes 7.0-8.0 mm ID for females and 8.0-9.0 mm ID for males. Tracheal stenosis occurs when diameter is reduced to <10 mm (symptomatic at <6 mm at rest) [PMID: 2653395].

Structural Components

Cartilaginous Rings:

• Number: 16-20 C-shaped hyaline cartilage rings
• Configuration: Open posteriorly (horseshoe shape)
• Height: Each ring 3-5 mm
• Spacing: Rings separated by fibrous tissue (annular ligaments) 1-3 mm apart
• Function: Maintain patency during negative intrathoracic pressure; prevent collapse during coughing and forced expiration [1,4]

The first tracheal ring is broader and often fused with the cricoid cartilage. The last tracheal ring is thickened inferiorly and forms the carina (ridge) between the two main bronchi [PMID: 8316192].

Trachealis Muscle (Posterior Membrane):

• Composition: Smooth muscle fibres (transverse and longitudinal)
• Attachment: Spans the gap between posterior cartilage ends
• Innervation: Parasympathetic (vagus) = contraction, Sympathetic = relaxation
• Function: Dynamic airway diameter regulation; contraction during cough to increase airflow velocity
• Clinical significance: Site of potential posterior tracheal wall injury during intubation; bronchospasm site in asthma [5,6]

Mucosal Lining:

• Epithelium: Pseudostratified ciliated columnar epithelium with goblet cells
• Cilia: Beat frequency 10-20 Hz, moving mucus at 5-20 mm/min towards pharynx
• Goblet cells: Produce mucus (95% water, 5% glycoproteins); 1-2 per 5 ciliated cells
• Submucosal glands: Mixed serous and mucous secretion; innervated by vagus
• Basement membrane: 50-80 micrometers thick [7,8]

Blood Supply

Arterial Supply:

• Superior trachea: Inferior thyroid artery (branch of thyrocervical trunk)
• Inferior trachea: Bronchial arteries, internal thoracic artery branches
• Segmental pattern: Blood supply enters laterally; vulnerable zone is anterolateral surface
• Anastomoses: Longitudinal vascular network along lateral walls [PMID: 9077296]

Venous Drainage:

• Superior trachea: Inferior thyroid veins to brachiocephalic veins
• Inferior trachea: Bronchial veins to azygos/hemiazygos systems
• Submucosal plexus: Rich venous network in submucosa [17]

Lymphatic Drainage:

• Cervical trachea: Pretracheal, paratracheal nodes (Level VI)
• Thoracic trachea: Tracheobronchial nodes (hilar), mediastinal nodes
• Clinical significance: Route for spread of bronchogenic carcinoma and pulmonary infections [18]

Relations

Cervical Trachea (C6 to Thoracic Inlet):

Thoracic Trachea (Thoracic Inlet to Carina):

Clinical Significance of Relations:

• Tracheo-oesophageal fistula can develop from prolonged cuff pressure or trauma
• Innominate artery erosion (tracheo-innominate fistula) = catastrophic haemorrhage
• Recurrent laryngeal nerve injury during thyroid/tracheal surgery causes vocal cord paralysis
• Mediastinal masses may compress trachea causing stridor [PMID: 8316192]

---

Carina

Anatomy of the Carina

Definition: The carina (Latin: "keel of a boat") is the cartilaginous ridge at the bifurcation of the trachea into the right and left main bronchi. It is a critical landmark in bronchoscopy and airway management [3,4].

Location:

• Vertebral level: T4-5 in neutral position (at the sternal angle/angle of Louis)
• Sternal reference: Level of manubriosternal junction
• Distance from incisors: Approximately 24-26 cm in adult males
• Movement: Descends 1-2 cm with inspiration; moves with head position (extension elevates, flexion depresses) [4]

Structure:

• Formed by the inferior margin of the last tracheal cartilage
• Sharp sagittal ridge in youth; becomes broader and rounder with age
• Normal carinal angle: 60-80 degrees (measured between main bronchi)
• Widening of carinal angle (>90 degrees) suggests subcarinal lymphadenopathy or mass [PMID: 11495610]

Bronchial Angles

Right Main Bronchus (RMB):

• Angle from midline: 20-30 degrees (typically 25 degrees)
• Vertical deviation: Only 25-30 degrees from vertical tracheal axis
• Clinical significance: More vertical alignment makes RMB more likely to receive:
  • Aspirated foreign bodies
  • Endobronchial intubation
  • Suction catheter passage [5,6]

Left Main Bronchus (LMB):

• Angle from midline: 40-50 degrees (typically 45 degrees)
• Horizontal deviation: More horizontal course
• Passes inferior to aortic arch (hence "hyparterial" bronchus)
• Clinical significance: Protected position reduces aspiration; more challenging to cannulate bronchoscopically [5,6]

Mnemonic for Bronchial Differences: "Right is Right for Aspiration"

• Right main bronchus receives aspirated material due to:
• Shorter length
• Wider diameter
• More vertical angle

---

Main Bronchi

Right Main Bronchus

Dimensions:

• Length: 2.0-2.5 cm (shortest main bronchus)
• Diameter: 12-16 mm (wider than left)
• Angle: 20-30 degrees from vertical [5,6]

Branches:

• Right upper lobe bronchus: Arises 2.5 cm from carina (before pulmonary artery crosses)
• Bronchus intermedius: Continues distally (4-5 cm length)
• Right middle lobe bronchus: Arises from anterior aspect of bronchus intermedius
• Right lower lobe bronchus: Continuation of bronchus intermedius

Eparterial Bronchus: The right upper lobe bronchus is termed "eparterial" because it arises above (epi = above) the level of the right pulmonary artery. This is unique to the right side [PMID: 16890765].

Clinical Relevance:

• Short length makes right upper lobe vulnerable to exclusion with endobronchial intubation
• When ETT advances into right main bronchus, right upper lobe may still be ventilated (tip between carina and RUL bronchus) or excluded (tip beyond RUL bronchus)
• Double-lumen tube placement: right-sided tubes have specific upper lobe ventilation slot [6]

Left Main Bronchus

Dimensions:

• Length: 4.5-5.0 cm (longer than right)
• Diameter: 10-12 mm (narrower than right)
• Angle: 40-50 degrees from vertical [5,6]

Branches:

• Left upper lobe bronchus: Arises 5 cm from carina
• Left lower lobe bronchus: Continuation beyond upper lobe bronchus

Hyparterial Bronchi: All left bronchi are "hyparterial" (hypo = below) as they arise below the left pulmonary artery. The left upper lobe bronchus is also more anterior [PMID: 16890765].

Clinical Relevance:

• Longer length provides margin of safety for endobronchial intubation
• Narrower diameter makes left-sided DLT more prone to malposition
• More horizontal angle makes bronchoscopic access more challenging
• Compression by enlarged left atrium or aortic aneurysm possible [6]

Comparison of Main Bronchi

---

Bronchial Tree

Lobar Bronchi (Second Order Bronchi)

Right Lung (3 Lobar Bronchi):

1. Right upper lobe bronchus: Eparterial; divides into 3 segmental bronchi (apical, posterior, anterior)
2. Right middle lobe bronchus: Arises from bronchus intermedius anteriorly; divides into 2 segmental bronchi (lateral, medial)
3. Right lower lobe bronchus: Largest; gives off superior segmental bronchus then 4 basal segments [9,10]

Left Lung (2 Lobar Bronchi):

1. Left upper lobe bronchus: Divides into upper division (2 segments) and lingular division (2 segments)
2. Left lower lobe bronchus: Superior segment then 3-4 basal segments [9,10]

Segmental Bronchi (Third Order Bronchi)

Right Lung Bronchopulmonary Segments (10):

Left Lung Bronchopulmonary Segments (8-10):

Clinical Significance of Bronchopulmonary Segments:

• Each segment is a functionally independent unit with its own bronchus, artery, and vein
• Allows for anatomical segmentectomy (lung cancer surgery)
• Segment orientation determines aspiration patterns (posterior segments affected in supine patients)
• Bronchoscopic localisation guides bronchoalveolar lavage sampling [PMID: 16890765]

Weibel Airway Generations Model

The Weibel model (1963) describes the dichotomous branching pattern of the tracheobronchial tree as 24 generations (numbered 0-23), providing a standardised anatomical framework for understanding airway mechanics and gas exchange [7,8].

Conducting Zone (Generations 0-16):

Respiratory Zone (Generations 17-23):

Key Concepts:

1. Progressive branching: Each generation roughly doubles the number of airways
2. Decreasing individual diameter: Airways become narrower with each generation
3. Increasing total cross-sectional area: Despite individual narrowing, total CSA increases dramatically (2.5 cm² at trachea to 5,000+ cm² at alveolar level)
4. Velocity decreases: As CSA increases, air velocity decreases (Bernoulli principle); velocity approaches zero at alveolar level, enabling diffusion-dominant gas exchange [7,8]

Transition Zones:

• Generation 16 (Terminal bronchioles): Last purely conducting airway; marks transition from conducting to respiratory zone
• Generation 17-19 (Respiratory bronchioles): First airways with alveoli in walls; transitional gas exchange
• Generation 23 (Alveolar sacs): Terminal clusters of alveoli; primary gas exchange site [9,10]

---

Bronchial Wall Structure

Histological Components

The bronchial wall composition changes progressively from proximal to distal airways, reflecting the transition from conduction to gas exchange functions [11,12].

Large Bronchi (Lobar/Segmental):

Bronchioles (<1 mm diameter):

Epithelial Cell Types

Ciliated Columnar Cells:

• Most abundant cell type (50-70% of epithelium)
• ~200 cilia per cell, 5-7 micrometers length
• Beat frequency: 10-20 Hz
• Metachronal wave moves mucus towards pharynx at 5-20 mm/min
• Impaired by smoking, infection, dehydration, anaesthesia [PMID: 16549862]

Goblet Cells:

• 15-20% of epithelial cells in large airways
• Produce mucus (mucin glycoproteins)
• Ratio goblet:ciliated cells = 1:5 normally
• Hyperplasia in chronic bronchitis, asthma (goblet cell metaplasia)
• Absent in terminal bronchioles [PMID: 16549862]

Basal Cells:

• Located on basement membrane
• Stem/progenitor cells for epithelial regeneration
• Do not reach airway lumen
• Express keratin 5/14 markers [PMID: 21660083]

Clara Cells (Club Cells):

• Non-ciliated secretory cells
• Predominant in bronchioles and terminal bronchioles
• Produce Clara cell secretory protein (CCSP/CC16)
• Functions: Surfactant-like material, xenobiotic metabolism, stem cell function
• Protective against oxidative injury [PMID: 18757275]

Neuroendocrine Cells:

• <1% of epithelial cells
• Cluster as neuroepithelial bodies (NEBs) at airway bifurcations
• Contain neurosecretory granules (serotonin, bombesin, calcitonin gene-related peptide)
• Oxygen-sensing function; may regulate local airflow
• Origin of small cell lung carcinoma [PMID: 18757275]

Submucosal Glands

Structure:

• Present from trachea to bronchi ~1 mm diameter
• Tubuloacinar glands with serous and mucous acini
• Duct opens onto airway surface
• Innervated by parasympathetic (stimulate secretion) and sympathetic (inhibit secretion) fibres [PMID: 16549862]

Secretions:

• Serous cells: Produce watery secretion with lysozyme, lactoferrin, IgA
• Mucous cells: Produce viscous mucin glycoproteins
• Normal secretion: 10-100 mL/day
• Hypertrophy (increased gland:wall ratio > Reid index >0.5) in chronic bronchitis [12]

Smooth Muscle

Distribution:

• Trachea/main bronchi: Posterior membrane (trachealis), minimal elsewhere
• Lobar/segmental bronchi: Helical bands in submucosa
• Bronchioles: Complete circumferential layer (most prominent)
• Respiratory bronchioles: Discontinuous spiral [11,12]

Innervation:

• Parasympathetic (vagus): Acetylcholine → M3 receptors → contraction (bronchoconstriction)
• Sympathetic: Noradrenaline → beta-2 receptors → relaxation (bronchodilation)
• Non-adrenergic non-cholinergic (NANC): Vasoactive intestinal peptide (relaxation), substance P (contraction)

Clinical Relevance:

• Bronchospasm: Smooth muscle contraction narrows airways; treated with beta-2 agonists, anticholinergics
• Airways <2 mm contribute 90% of total airway resistance in bronchospasm
• Asthma: Smooth muscle hypertrophy and hyperreactivity [PMID: 17379849]

Cartilage

Distribution by Airway Level:

Function:

• Maintains airway patency against negative intrathoracic pressure
• Prevents collapse during forced expiration/coughing
• Allows flexibility for respiratory movements [11]

Clinical Relevance:

• Tracheomalacia: Cartilage weakness causing dynamic collapse
• Bronchiectasis: Cartilage destruction with chronic infection
• Relapsing polychondritis: Autoimmune cartilage inflammation [PMID: 8316192]

---

Bronchioles

Terminal Bronchioles (Generation 16)

Definition: Terminal bronchioles are the final generation of purely conducting airways, representing the transition point between the conducting zone and the respiratory zone [9,10].

Characteristics:

• Diameter: 0.5-1.0 mm
• Number: Approximately 65,000 in adult lung
• Epithelium: Simple cuboidal with Clara cells; no goblet cells
• Wall structure: No cartilage, prominent smooth muscle, rich elastic tissue
• Function: Conduct air only; no gas exchange [7,8]

Clinical Relevance:

• Small airway disease (chronic bronchiolitis, bronchiolitis obliterans) affects terminal bronchioles
• Resistance contribution: <10% of total airway resistance in health (due to parallel arrangement and large total CSA)
• In disease, small airway resistance increases dramatically [PMID: 4835221]

Respiratory Bronchioles (Generations 17-19)

Definition: Respiratory bronchioles represent the transitional airways where gas exchange begins, characterised by scattered alveoli in their walls [9,10].

Characteristics:

• Diameter: 0.4 mm
• Number: Approximately 500,000
• Epithelium: Simple cuboidal transitioning to Type I pneumocytes
• Alveoli: Scattered outpouchings from walls; increase in number with each generation
• Smooth muscle: Spiral bands around alveolar openings
• Function: Both conduction and gas exchange [7,8]

Clinical Relevance:

• Respiratory bronchiolitis: Smoking-related inflammation at this level
• Centrilobular emphysema: Destruction begins at respiratory bronchiole level
• ARDS: Inflammation at respiratory bronchiole-alveolar junction [PMID: 4835221]

Alveolar Ducts (Generations 20-22)

Definition: Alveolar ducts are airways whose walls are composed almost entirely of alveoli, representing the primary ventilatory pathway to alveolar sacs [9,10].

Characteristics:

• Diameter: 0.3 mm
• Number: Approximately 8 million
• Structure: Thin-walled channels; walls = alveolar openings separated by rings of smooth muscle and elastic tissue
• Epithelium: Type I and II pneumocytes (alveolar epithelium)
• Function: Gas exchange and final air conduction [7,8]

Alveolar Sacs (Generation 23)

Definition: Alveolar sacs are terminal clusters of alveoli at the end of alveolar ducts, representing the final structural unit of the respiratory tree [9,10].

Characteristics:

• Structure: Grape-like cluster of 2-11 alveoli
• Number: Approximately 8 million sacs
• Alveoli per sac: Average 4-5 alveoli
• Function: Terminal gas exchange unit [7,8]

---

Alveoli

Macroscopic Features

Numbers and Surface Area:

• Total alveoli: ~300 million (range 200-600 million) [13,14]
• Surface area: 70-100 m² (tennis court equivalent)
• Diameter: 200-300 micrometers (average 250 micrometers)
• Wall thickness: 0.1-0.2 micrometers (excluding blood vessel)

Distribution:

• Alveoli first appear in respiratory bronchioles (Gen 17)
• Density increases towards alveolar sacs
• Interalveolar septum contains shared capillary network
• Alveolar pores (pores of Kohn) allow collateral ventilation [13,14]

Alveolar Wall Structure

Interalveolar Septum Components:

1. Alveolar epithelium (Type I and II pneumocytes)
2. Epithelial basement membrane
3. Interstitial space (thin on one side, thicker on other)
4. Capillary basement membrane
5. Capillary endothelium
6. Elastic fibres and collagen (interstitial matrix)

Thin Side vs Thick Side:

• Thin side: Basement membranes fused; minimal interstitium (0.2-0.3 micrometers total); primary gas exchange site
• Thick side: Separated basement membranes with interstitium (1-2 micrometers); contains collagen, elastic fibres; provides structural support [15,16]

Type I Pneumocytes (Alveolar Epithelial Cells Type I)

Characteristics:

• Proportion: 8-11% of alveolar cells numerically
• Surface coverage: 95-97% of alveolar surface area
• Morphology: Extremely thin (0.1-0.2 micrometers), flattened, squamous
• Cytoplasm: Minimal organelles; flattened nucleus
• Junctions: Tight junctions with other Type I and Type II cells [13,14]

Functions:

• Primary gas exchange surface (optimised by minimal thickness)
• Barrier function (prevent fluid leak into alveoli)
• Water transport (aquaporin channels)
• Cannot proliferate; derived from Type II cells [PMID: 16172622]

Clinical Relevance:

• Extremely vulnerable to injury (thin, limited regenerative capacity)
• Damaged in ARDS, pneumonia, inhalation injury
• Loss leads to increased alveolar permeability (pulmonary oedema) [PMID: 16172622]

Type II Pneumocytes (Alveolar Epithelial Cells Type II)

Characteristics:

• Proportion: 60-80% of alveolar cells numerically (but only 3-5% surface area)
• Morphology: Cuboidal, located in alveolar corners
• Cytoplasm: Abundant organelles, lamellar bodies (surfactant storage)
• Microvilli: Apical surface
• Size: 10-12 micrometers diameter [13,14]

Functions:

Clinical Relevance:

• Neonatal RDS: Type II pneumocyte immaturity (surfactant deficiency)
• ARDS: Type II cell damage impairs surfactant function and regeneration
• Drug toxicity: Amiodarone, bleomycin cause Type II cell damage (phospholipidosis)
• COVID-19: SARS-CoV-2 targets Type II pneumocytes via ACE2 receptors [PMID: 16172622]

Surfactant

Composition:

• Lipids (90%): Dipalmitoylphosphatidylcholine (DPPC) ~50%, other phospholipids, cholesterol
• Proteins (10%): SP-A, SP-B, SP-C, SP-D (surfactant proteins)

Properties and Functions:

LaPlace Law and Surfactant: Without surfactant, small alveoli (high P = 2T/r) would empty into large alveoli. Surfactant reduces surface tension proportionally more in smaller alveoli, equalising pressures and preventing collapse [PMID: 17189321].

Surfactant Proteins:

Clinical Applications:

• Exogenous surfactant (beractant, poractant): Treatment for neonatal RDS
• Adult ARDS: Surfactant dysfunction; exogenous surfactant trials disappointing
• Surfactant biomarkers: SP-D elevated in IPF, ARDS [PMID: 17189321]

Blood-Gas Barrier

Definition: The blood-gas barrier is the extremely thin tissue interface across which gas exchange occurs between alveolar air and pulmonary capillary blood [15,16].

Structure (from alveolus to blood):

1. Surfactant layer: Thin film on alveolar surface
2. Alveolar epithelium: Type I pneumocyte (0.1-0.2 micrometers)
3. Epithelial basement membrane: Fused with endothelial BM on thin side
4. Capillary endothelium: Continuous (non-fenestrated)
5. Plasma: Minimal unstirred layer
6. Red blood cell membrane: Final barrier

Thickness:

• Thin portion: 0.2-0.3 micrometers (fused basement membranes) - primary gas exchange
• Thick portion: 1-2 micrometers (separated BMs with interstitium) - structural support
• Harmonic mean thickness: 0.5 micrometers (effective diffusion distance) [15,16]

Surface Area and Diffusion:

• Alveolar surface area: 70-100 m²
• Capillary surface area: ~60-80 m² (similar to alveolar area)
• Capillary blood volume: 60-140 mL (increases with exercise)
• Diffusing capacity (DLCO): Reflects barrier integrity [PMID: 6488926]

Fick's Law of Diffusion Applied to Blood-Gas Barrier:

V̇gas = (A × D × ΔP) / T

Where:

• V̇gas = Volume of gas transferred per unit time
• A = Surface area (70-100 m²)
• D = Diffusion coefficient (gas-specific)
• ΔP = Partial pressure gradient (e.g., PAO2 - PcapO2)
• T = Barrier thickness (0.5 micrometers)

Clinical Relevance:

• Pulmonary oedema increases T → impaired diffusion
• Emphysema decreases A → reduced diffusion
• Pulmonary fibrosis increases T → restrictive pattern with impaired gas exchange
• Anaemia reduces Hb availability → functional diffusion impairment [PMID: 6488926]

Alveolar Pores

Pores of Kohn:

• Size: 3-13 micrometers diameter
• Location: Interalveolar septum; connect adjacent alveoli
• Number: 20-30 per alveolus
• Function: Collateral ventilation; equalise pressure between alveoli
• Develop: After birth (absent in neonates)
• Clinical significance: Allow ventilation of alveoli beyond obstructed airways; may allow infection spread [PMID: 16172622]

Lambert Canals:

• Connect respiratory bronchioles to adjacent alveoli
• Provide collateral ventilation bypass

Martin Channels:

• Connect small bronchioles
• Additional collateral pathway [PMID: 16172622]

---

Pulmonary Blood Supply

Pulmonary Circulation

Function: The pulmonary circulation delivers deoxygenated blood from the right ventricle to the alveolar capillaries for gas exchange, returning oxygenated blood to the left atrium [17,18].

Pulmonary Arteries:

• Origin: Pulmonary trunk from right ventricle
• Bifurcation: Left and right pulmonary arteries at T5-6 level
• Course: Follow bronchial tree dichotomously
• Wall thickness: Thin-walled, low pressure (media:lumen ratio 3:1 vs 10:1 in systemic)
• Blood flow: ~5 L/min at rest (equals systemic cardiac output) [17]

Pulmonary Capillaries:

• Diameter: 7-10 micrometers
• Length: ~10 micrometers (individual segments)
• Configuration: Sheet-like network in interalveolar septum (not tubes)
• Transit time: 0.75 seconds at rest (reduced to 0.25 seconds with exercise)
• Blood volume: 60-140 mL (recruitment with increased output)
• Surface area: ~60-80 m² (matches alveolar surface) [17]

Pulmonary Veins:

• Course: Run in interlobular septa (separated from arteries/bronchi)
• Drainage: 4 pulmonary veins to left atrium (2 right, 2 left)
• Wall: Thin-walled; contain cardiac muscle extensions (pacemaker activity → AF focus)
• Clinical significance: Pulmonary vein isolation for atrial fibrillation ablation [17]

Haemodynamic Characteristics:

Bronchial Circulation

Function: The bronchial circulation provides oxygenated blood for nutritive supply to airway walls, pleura, and supporting structures. It is a systemic circulation to the lungs [17,18].

Bronchial Arteries:

• Origin: Variable; usually 1-2 left (from thoracic aorta), 1 right (from intercostal or internal thoracic)
• Course: Follow bronchi to level of respiratory bronchioles
• Blood flow: 1-2% of cardiac output (50-100 mL/min)
• Supplies: Bronchial wall, large pulmonary vessels, pleura, hilar lymph nodes [18]

Bronchial Veins:

• Proximal airways: Drain to azygos/hemiazygos veins (true bronchial veins)
• Distal airways: Anastomose with pulmonary veins (bronchopulmonary veins)
• Clinical significance: Bronchial-pulmonary anastomoses contribute 1-3% of physiological shunt [18]

Clinical Relevance of Bronchial Circulation:

• Massive haemoptysis: Usually bronchial artery origin (hypertrophied in chronic infection)
• Bronchial artery embolisation: Treatment for massive haemoptysis
• Bronchial artery injury: Risk during thoracic surgery
• Hypoxic pulmonary vasoconstriction: Does not affect bronchial circulation [PMID: 9077296]

Pulmonary-Bronchial Anastomoses

Location:

• Precapillary anastomoses between bronchial and pulmonary arteries
• Postcapillary anastomoses between bronchial veins and pulmonary veins
• Intrapulmonary bronchopulmonary veins [18]

Physiological Significance:

• Contribute to normal physiological shunt (2-5% of cardiac output)
• Normally small and clinically insignificant
• May enlarge in chronic lung disease (bronchiectasis, Eisenmenger syndrome)
• Bronchial artery hypertrophy can cause massive haemoptysis [PMID: 9077296]

---

Lymphatics

Pulmonary Lymphatic Drainage

Distribution:

• Superficial plexus: Subpleural network draining visceral pleura and peripheral lung
• Deep plexus: Peribronchial and perivascular network draining central lung
• Communication: Pleural lymphatics communicate with deep system at hilum [18]

Drainage Pathway:

1. Intrapulmonary lymph nodes: Small nodes along bronchi
2. Bronchopulmonary nodes (hilar): At lung hilum
3. Tracheobronchial nodes: At carina and main bronchi
4. Paratracheal nodes: Along trachea
5. Mediastinal trunks: To thoracic duct (left) or right lymphatic duct

Functions:

• Fluid balance: Remove interstitial fluid (prevents pulmonary oedema)
• Immune surveillance: Antigen presentation, lymphocyte activation
• Particle clearance: Remove inhaled particles reaching alveoli
• Protein removal: Clear extravasated plasma proteins [18]

Clinical Relevance:

• Lymphangitic carcinomatosis: Cancer cells in lymphatics
• Sarcoidosis: Hilar lymphadenopathy
• Tuberculosis: Primary complex includes hilar lymphadenopathy
• Lung transplant: Lymphatic disruption impairs fluid clearance initially [PMID: 8316192]

---

Nerve Supply

Autonomic Innervation

Parasympathetic Supply (Vagus):

• Origin: Dorsal motor nucleus of vagus, nucleus ambiguus
• Course: Vagus nerve → pulmonary plexuses → airways
• Ganglia: Intrinsic ganglia in bronchial walls
• Neurotransmitter: Acetylcholine (ACh)
• Effects:
  • Bronchoconstriction (M3 muscarinic receptors on smooth muscle)
  • Increased mucus secretion (submucosal glands)
  • Vasodilation (bronchial vessels)
  • "Slowed mucociliary clearance [PMID: 17379849]"

Sympathetic Supply:

• Origin: T2-T5 sympathetic ganglia
• Course: Sympathetic chain → pulmonary plexuses → airways
• Neurotransmitter: Noradrenaline (direct), Adrenaline (circulating)
• Effects:
  • Bronchodilation (beta-2 adrenergic receptors)
  • Decreased mucus secretion
  • Vasoconstriction (alpha receptors)
  • "Inhibition of inflammatory mediator release [PMID: 17379849]"

Non-Adrenergic Non-Cholinergic (NANC) System:

• Inhibitory NANC (relaxation):
  • Vasoactive intestinal peptide (VIP)
  • Nitric oxide (NO)
  • "Effect: Bronchodilation"
• Excitatory NANC (contraction):
  • Substance P
  • Neurokinin A
  • "Effect: Bronchoconstriction, neurogenic inflammation [PMID: 17379849]"

Sensory Innervation

Receptor Types:

Clinical Relevance:

• Cough reflex: RARs and C-fibres mediated; inhibited by opioids and anaesthesia
• Bronchospasm: Vagal reflex bronchoconstriction
• Laryngospasm: Protective reflex; problematic during anaesthesia
• Pulmonary oedema: J receptor stimulation causes dyspnoea and rapid shallow breathing [PMID: 17379849]

Pulmonary Plexuses

Anterior Pulmonary Plexus:

• Located anterior to lung root
• Smaller than posterior plexus
• Contains sympathetic and parasympathetic fibres

Posterior Pulmonary Plexus:

• Located posterior to lung root
• Larger plexus
• Main source of airway innervation
• Contains vagal fibres with contributions from sympathetic chain [18]

---

Applied Anatomy

Bronchoscopy Landmarks

Flexible Bronchoscopy Anatomical Sequence:

Bronchoscopy Orientation:

• Patient supine, head-end of bed approach
• On screen: Superior = 12 o'clock, Posterior = 6 o'clock
• Right bronchus = left side of screen (mirror image)
• Left bronchus = right side of screen [PMID: 16890765]

ETT Positioning

Optimal Position:

• Tip location: 3-5 cm above carina (at mid-trachea)
• CXR reference: Tip at T5-T7 level; at or below level of clavicular heads
• Above carina by: ≥2 cm to prevent endobronchial migration with head movement [19,20]

Head Position Effects:

• Flexion (chin to chest): ETT advances 2-3 cm towards carina
• Extension (head back): ETT withdraws 2 cm towards cords
• Lateral rotation: ETT moves 0.5-1 cm
• Neutral to flexion: Risk of endobronchial intubation
• Neutral to extension: Risk of extubation [PMID: 2653395]

Formulae for ETT Depth:

Endobronchial Intubation:

• More common on right (shorter, more vertical RMB)
• Signs: Unilateral chest movement, absent breath sounds (usually left)
• Consequences: Atelectasis of non-ventilated lung, hypoxia, hyperinflation of ventilated lung
• Management: Withdraw ETT until bilateral breath sounds, confirm with CXR or bronchoscopy [19,20]

One-Lung Ventilation

Anatomical Considerations for Double-Lumen Tubes (DLT):

Left-Sided DLT (More Common):

• Bronchial lumen: Positioned in LMB (longer, easier to position)
• Tracheal lumen: Ventilates right lung via main carina
• Margin of safety: LMB length (5 cm) provides positioning tolerance
• Risk: Left upper lobe obstruction if advanced too far [PMID: 16890765]

Right-Sided DLT:

• Bronchial lumen: Positioned in RMB (short, 2.5 cm)
• Murphy eye: Side port for RUL ventilation (critical)
• Margin of safety: Only 2.5 cm before RUL bronchus
• Indication: Left pneumonectomy, LMB lesion, left lung transplant [PMID: 16890765]

Bronchial Blocker Anatomy:

• Placed via ETT into target bronchus (usually mainstem)
• Inflated balloon occludes ventilation to that lung
• Less precise than DLT; may migrate
• Useful when DLT contraindicated (difficult airway, paediatrics) [PMID: 16890765]

Chest Drain Insertion

Anatomical Landmarks (Safe Triangle):

• Anterior border: Lateral border of pectoralis major
• Posterior border: Anterior border of latissimus dorsi
• Inferior border: 5th intercostal space (nipple line in males)
• Superior border: Axillary apex

Intercostal Space Anatomy:

• Neurovascular bundle (vein, artery, nerve) runs inferior to each rib
• Insert drain above the rib (avoid VAN bundle)
• 4th-5th intercostal space at mid-axillary line standard site [18]

Structures at Risk:

• Intercostal vessels (bleeding)
• Lung parenchyma (pneumothorax, air leak)
• Diaphragm (especially with elevated diaphragm or hepatomegaly)
• Heart and great vessels (rare, medial insertion)
• Long thoracic nerve (winging scapula if injured) [18]

Tracheostomy Anatomy

Surgical Tracheostomy:

• Level: Usually 2nd-3rd tracheal ring (below isthmus)
• Structures divided: Skin, platysma, strap muscles (separated or divided), thyroid isthmus (retracted or divided), pretracheal fascia, trachea
• Key relations: Inferior thyroid veins, thyroidea ima artery (variable), brachiocephalic artery (deep, more distal) [PMID: 8316192]

Percutaneous Tracheostomy:

• Level: 1st-3rd tracheal ring
• Technique: Seldinger technique with bronchoscopic guidance
• Landmarks: Cricoid cartilage (superior), sternal notch (inferior)
• Complications: False passage, posterior tracheal wall injury, bleeding [PMID: 8316192]

---

Clinical Correlations

Aspiration Patterns

Right-Sided Predominance:

• RMB anatomy (shorter, wider, more vertical) favors aspiration to right lung
• Supine patient: Aspirate to posterior segment of RUL, superior segment of RLL
• Right lateral position: Right middle lobe, right lower lobe lateral/posterior segments
• Upright patient: Right lower lobe basal segments [5,6]

Clinical Significance:

• Right lower lobe pneumonia common after aspiration
• Right lung atelectasis more common in intubated patients
• Right-sided empyema after aspiration more frequent [5,6]

Bronchopulmonary Segments in Disease

Common Segment Involvement:

Indigenous Health Considerations

Aboriginal and Torres Strait Islander Populations:

• Higher rates of bronchiectasis (up to 14x general population)
• Increased chronic respiratory disease burden
• Higher rates of community-acquired pneumonia
• Tuberculosis incidence 5-6x higher than non-Indigenous Australians
• Access barriers to specialist respiratory services in remote areas
• Cultural considerations for bronchoscopy consent and procedures [PMID: 30356780]

Maori and Pacific Islander Populations (New Zealand):

• Higher rates of bronchiectasis and COPD
• Increased pneumonia hospitalisation rates
• Lower lung function norms (different prediction equations may be needed)
• Cultural protocols for invasive procedures (whanau involvement)
• Te Whatu Ora Health New Zealand initiatives for respiratory equity [PMID: 30356780]

Clinical Implications:

• Consider bronchiectasis in younger patients with recurrent chest infections
• Cultural liaison and interpreter services for consent discussions
• Whanau/family involvement in treatment decisions
• Address access barriers through telehealth and outreach services
• Smoking cessation support culturally tailored [PMID: 30356780]

---

Common Errors and Pitfalls

Anatomical Misconceptions

Clinical Errors

---

Summary Table: Key Dimensions

---

SAQ Practice Questions

SAQ 1: Tracheal Anatomy and Applied Considerations (15 marks)

Question: A 65-year-old male with COPD requires prolonged mechanical ventilation and is planned for percutaneous tracheostomy.

a) Describe the anatomy of the trachea, including its dimensions, structure, and key relations (8 marks) b) Outline the anatomical considerations for percutaneous tracheostomy insertion (4 marks) c) Explain how tracheal anatomy is relevant to endotracheal tube positioning (3 marks)

---

Model Answer:

a) Tracheal Anatomy (8 marks)

Definition and Extent: The trachea is a fibrocartilaginous tube extending from the cricoid cartilage (C6) to the carina (T4-5), conducting air from the larynx to the bronchi.

Dimensions:

• Length: 10-12 cm (cervical 5 cm, thoracic 5-7 cm)
• External diameter: 2.3-2.7 cm (male), 2.0-2.4 cm (female)
• Internal diameter: 1.8-2.5 cm

Structural Components:

• Cartilaginous rings: 16-20 C-shaped hyaline cartilage rings, open posteriorly
• Trachealis muscle: Smooth muscle bridging posterior cartilage ends; dynamic diameter regulation
• Mucosa: Pseudostratified ciliated columnar epithelium with goblet cells
• Submucosa: Submucosal glands, vessels, nerves, lymphatics

Blood Supply:

• Superior: Inferior thyroid artery
• Inferior: Bronchial arteries
• Venous drainage: Inferior thyroid veins, bronchial veins

Key Relations:

• Cervical trachea:
  • "Anterior: Thyroid isthmus (rings 2-4), strap muscles, inferior thyroid veins"
  • "Posterior: Oesophagus, recurrent laryngeal nerves"
  • "Lateral: Thyroid lobes, carotid sheaths"
• Thoracic trachea:
  • "Anterior: Brachiocephalic artery (crosses from left to right), aortic arch"
  • "Posterior: Oesophagus, vertebral column"
  • "Right: SVC, azygos vein, right vagus"
  • "Left: Aortic arch, left recurrent laryngeal nerve"

b) Anatomical Considerations for Percutaneous Tracheostomy (4 marks)

Level of Insertion:

• Between 1st-3rd tracheal rings (below cricoid, avoiding 1st ring to reduce stenosis risk)
• Ideally 2nd-3rd ring interspace

Landmarks:

• Superior: Cricoid cartilage (most reliable landmark)
• Inferior: Sternal notch

Structures to Avoid:

• Thyroid isthmus (retract superiorly or divide)
• Inferior thyroid veins (anterior, midline)
• Thyroidea ima artery (variable, midline)
• Brachiocephalic artery (low tracheostomy risk, especially in obese or short neck)
• Posterior tracheal wall and oesophagus (avoid deep penetration)

Safe Technique:

• Bronchoscopic guidance to visualise needle entry
• Maintain endotracheal tube cuff inflation during dilatation
• Perpendicular approach to anterior tracheal wall

c) Tracheal Anatomy and ETT Positioning (3 marks)

Optimal Position:

• ETT tip 3-5 cm above carina (mid-trachea)
• Radiographic reference: Tip at T5-T7 level

Head Position Effects:

• Flexion moves ETT 2-3 cm distally (risk of endobronchial intubation)
• Extension moves ETT 2 cm proximally (risk of extubation)

Formulae:

• Oral depth = (Height cm ÷ 10) + 5 cm
• Verification: CXR, cuff palpation at sternal notch (should not be palpable)

Clinical Relevance:

• Tracheal length determines safe ETT positioning range
• Position must be reassessed after any head movement
• Carina at T4-5 provides reference for tip placement

---

SAQ 2: Alveolar Structure and Gas Exchange (15 marks)

Question: A patient with ARDS has severe hypoxaemia despite high FiO2. You are discussing the anatomical basis of impaired gas exchange.

a) Describe the structure of the alveolus, including cell types and their functions (6 marks) b) Describe the structure and dimensions of the blood-gas barrier (4 marks) c) Explain how alveolar anatomy is disrupted in ARDS and the consequences for gas exchange (5 marks)

---

Model Answer:

a) Alveolar Structure (6 marks)

Macroscopic Features:

• Total number: ~300 million alveoli
• Diameter: 200-300 micrometers
• Total surface area: 70-100 m² (tennis court equivalent)

Alveolar Wall Structure: The alveolar wall (interalveolar septum) comprises:

• Alveolar epithelium (Type I and II pneumocytes)
• Epithelial basement membrane
• Interstitial space (minimal on thin side)
• Capillary basement membrane (fused with epithelial BM on thin side)
• Capillary endothelium
• Capillary lumen with red blood cells

Cell Types:

Type I Pneumocytes:

• 8-11% of cells numerically, but 95-97% of surface area
• Extremely thin squamous cells (0.1-0.2 micrometers)
• Function: Primary gas exchange surface
• Cannot replicate; derived from Type II cells
• Vulnerable to injury

Type II Pneumocytes:

• 60-80% of cells numerically, only 3-5% of surface area
• Cuboidal cells in alveolar corners
• Contain lamellar bodies (surfactant storage)
• Functions:
  • Surfactant synthesis, storage, secretion, and recycling
  • Progenitor cells for Type I pneumocytes (epithelial regeneration)
  • Active fluid clearance (ENaC sodium channels)
  • Immune functions (SP-A, SP-D production)

Other Components:

• Alveolar macrophages: Phagocytosis, immune surveillance
• Pores of Kohn: Interalveolar connections for collateral ventilation
• Surfactant: Reduces surface tension, prevents collapse

b) Blood-Gas Barrier Structure (4 marks)

Definition: The blood-gas barrier is the thin tissue layer across which oxygen and carbon dioxide diffuse between alveolar air and pulmonary capillary blood.

Components (alveolus to blood):

1. Surfactant layer
2. Type I pneumocyte cytoplasm (0.1-0.2 micrometers)
3. Fused epithelial and endothelial basement membranes
4. Capillary endothelium
5. Plasma layer
6. Red blood cell membrane

Dimensions:

• Thin portion: 0.2-0.3 micrometers (fused basement membranes; primary gas exchange)
• Thick portion: 1-2 micrometers (separated BMs with interstitium; structural support)
• Harmonic mean thickness: ~0.5 micrometers

Optimisation for Gas Exchange:

• Minimal diffusion distance (Fick's law: diffusion inversely proportional to thickness)
• Large surface area (70-100 m² alveolar, 60-80 m² capillary)
• Thin barrier on at least one side of septum
• Capillary transit time (0.75 seconds) allows equilibration

c) ARDS Alveolar Disruption and Consequences (5 marks)

Pathophysiology of Alveolar Injury in ARDS:

Phase 1 - Exudative (Days 1-7):

• Type I pneumocyte injury and necrosis (vulnerable to oxidative injury, inflammation)
• Loss of epithelial barrier integrity
• Protein-rich exudate floods alveoli
• Hyaline membrane formation (fibrin + necrotic cellular debris)
• Type II pneumocyte damage → impaired surfactant production

Phase 2 - Proliferative (Days 7-21):

• Type II pneumocyte hyperplasia (attempted regeneration)
• Myofibroblast proliferation
• Early fibrosis in interstitium
• Capillary endothelial damage

Phase 3 - Fibrotic (>21 days):

• Interstitial fibrosis with thickened septa
• Type I pneumocyte coverage incomplete
• Alveolar architecture destroyed

Consequences for Gas Exchange:

Clinical Manifestation:

• Severe hypoxaemia with high shunt fraction (Qs/Qt >30%)
• Increased A-a gradient despite high FiO2
• Reduced compliance (stiff lungs)
• Increased dead space (elevated VD/VT)

Therapeutic Implications:

• Lung protective ventilation (low tidal volume to limit further injury)
• PEEP to recruit collapsed alveoli and maintain patency
• Prone positioning to improve V/Q matching
• Limited benefit of high FiO2 for shunt physiology

---

Viva Scenarios

Viva Scenario 1: Bronchoscopy Anatomy and ETT Positioning

Stem: You are the ICU registrar. A patient has been intubated emergently, and the CXR shows the ETT tip at the level of the carina. You are asked to adjust the ETT under bronchoscopic guidance.

---

Examiner: Describe the anatomy you would expect to see as you pass the bronchoscope through the ETT and into the airway.

Candidate: As I pass the bronchoscope through the endotracheal tube and emerge from its tip, I would expect to be in the lower trachea approaching the carina.

The trachea appears as a tubular structure with:

• Anterior and lateral walls: C-shaped cartilaginous rings visible as pale ridges
• Posterior wall: Smooth membranous portion (trachealis muscle) without cartilage
• Mucosa: Pink, glistening pseudostratified columnar epithelium

The carina would be visible as the bifurcation point:

• Sharp sagittal ridge in younger patients, more rounded in elderly
• Divides the airway into right and left main bronchi
• Normal carinal angle is 60-80 degrees

---

Examiner: What are the key differences between the right and left main bronchi?

Candidate: The right and left main bronchi have several important anatomical differences:

Right Main Bronchus:

• Length: Shorter (2.0-2.5 cm)
• Diameter: Wider (12-16 mm)
• Angle: More vertical (20-30 degrees from vertical)
• Relation: Eparterial - right upper lobe bronchus arises above the pulmonary artery
• First branch: Right upper lobe bronchus at 2.5 cm from carina

Left Main Bronchus:

• Length: Longer (4.5-5.0 cm)
• Diameter: Narrower (10-12 mm)
• Angle: More horizontal (40-50 degrees from vertical)
• Relation: Hyparterial - passes beneath the aortic arch
• First branch: Left upper lobe bronchus at 5 cm from carina

---

Examiner: Why is right endobronchial intubation more common than left?

Candidate: Right endobronchial intubation is more common due to the anatomical configuration of the right main bronchus:

1. More vertical angle: The RMB deviates only 25 degrees from the tracheal axis, making it the more direct continuation of the airway. The LMB deviates 45 degrees, requiring a sharper turn.

2. Shorter length: The short RMB (2.5 cm) means there's less distance for the ETT to travel before entering a lobar bronchus.

3. Wider diameter: The larger caliber of the RMB (12-16 mm vs 10-12 mm) more easily accommodates an ETT.

These factors explain why approximately 90% of unintentional endobronchial intubations occur on the right side.

---

Examiner: How would you determine the optimal position for the ETT?

Candidate: I would determine optimal ETT position using multiple methods:

Optimal Position:

• ETT tip should be 3-5 cm above the carina
• Radiographically, this corresponds to T5-T7 level, approximately at the level of the clavicular heads

Bronchoscopic Confirmation:

• Visualise carina through the ETT
• Tip should be at least 2-3 cm above carina
• Both main bronchi should be visible beyond the tube tip

Practical Method: Using the formula: Depth at teeth = (Height in cm ÷ 10) + 5 cm

For example, a 170 cm patient: (170 ÷ 10) + 5 = 22 cm at the teeth

Head Position Consideration:

• After positioning, I would note that head flexion moves the ETT distally by 2-3 cm, and extension moves it proximally by 2 cm
• Position should be rechecked after any head movement

---

Examiner: The patient's head was flexed during intubation and is now in neutral position. What adjustment would you expect to make?

Candidate: If the head was flexed during intubation and is now in neutral position, the ETT would have moved proximally by approximately 2 cm when the head was extended to neutral.

Since the CXR shows the tip at the carina (too low), and the head is now in neutral, this means:

• The tube was inserted too deeply during the flexed intubation
• The current position with neutral head is at the carina level

I would need to withdraw the ETT by approximately 3-4 cm to achieve the optimal position of 3-5 cm above the carina.

After repositioning, I would:

1. Confirm with repeat bronchoscopy or CXR
2. Secure the tube at the new depth
3. Document the depth at the teeth/lips
4. Reassess after any further head position changes

---

Examiner: What are the consequences of unrecognised endobronchial intubation?

Candidate: Unrecognised endobronchial intubation can have serious consequences:

Immediate Consequences:

• Atelectasis of the excluded lung: Usually left lung (90% of endobronchial intubations are right-sided)
• Hypoxia: Shunt through non-ventilated lung
• Hyperinflation of ventilated lung: Entire tidal volume delivered to one lung

Ventilator-Related Consequences:

• Increased airway pressures: Higher resistance and reduced compliance
• Barotrauma: Pneumothorax of the ventilated lung
• Ventilator-induced lung injury: Overdistension of single lung

Delayed Consequences:

• Ventilator-associated pneumonia: Atelectatic lung at higher risk
• Prolonged hypoxia: May cause end-organ damage
• Delayed recognition: May be mistaken for other causes of hypoxia or increased pressures

Prevention:

• Routine auscultation of bilateral breath sounds
• CXR confirmation after intubation and position changes
• Low threshold for bronchoscopy if position uncertain
• Awareness of head position effects on ETT position

---

Viva Scenario 2: Alveolar Anatomy and Gas Exchange

Stem: You are asked to teach a medical student about alveolar anatomy during an ICU teaching session. A patient with severe pneumonia and ARDS is being ventilated with high FiO2.

---

Examiner: Describe the structure of the alveolus and the blood-gas barrier.

Candidate: The alveolus is the terminal gas exchange unit of the respiratory system.

Alveolar Structure:

• Number: Approximately 300 million alveoli per lung
• Diameter: 200-300 micrometers
• Total surface area: 70-100 m² (equivalent to a tennis court)
• Shape: Polyhedral with flat walls shared between adjacent alveoli

Alveolar Wall (Interalveolar Septum): The wall contains:

1. Type I pneumocytes: Cover 95-97% of surface area, extremely thin (0.1-0.2 micrometers), specialised for gas exchange
2. Type II pneumocytes: Cuboidal cells in alveolar corners, produce surfactant, serve as progenitor cells for Type I cells
3. Alveolar macrophages: Phagocytic cells for immune defense
4. Capillary network: Dense network of pulmonary capillaries
5. Interstitium: Minimal connective tissue with elastic fibres

Blood-Gas Barrier: This is the tissue layer across which gas diffusion occurs, measuring only 0.2-0.5 micrometers in thickness.

Components from alveolus to blood:

1. Surfactant layer
2. Type I pneumocyte cytoplasm (0.1-0.2 micrometers)
3. Fused basement membranes
4. Capillary endothelium
5. Plasma
6. Red blood cell membrane

The barrier is optimised for diffusion by being extremely thin while maintaining structural integrity.

---

Examiner: What is the function of Type II pneumocytes and why are they important in ARDS?

Candidate: Type II pneumocytes have multiple critical functions:

Primary Functions:

1. Surfactant Production: They synthesise, store (in lamellar bodies), secrete, and recycle pulmonary surfactant
2. Epithelial Regeneration: They serve as progenitor cells for Type I pneumocytes after injury
3. Fluid Clearance: Active sodium transport via ENaC channels drives water absorption from alveolar space
4. Immune Functions: Produce surfactant proteins A and D which opsonise pathogens

Surfactant Composition and Function:

• 90% lipids (DPPC - dipalmitoylphosphatidylcholine is the main component)
• 10% proteins (SP-A, SP-B, SP-C, SP-D)
• Reduces surface tension from 70 to 5-25 mN/m
• Prevents alveolar collapse by the LaPlace law (P = 2T/r)

Importance in ARDS: In ARDS, Type II pneumocytes are damaged by the inflammatory process, leading to:

1. Reduced surfactant production: Leads to increased surface tension and alveolar collapse
2. Impaired fluid clearance: Contributes to alveolar flooding and oedema
3. Loss of regenerative capacity: Type I cells cannot be replaced, leading to persistent barrier dysfunction
4. Altered surfactant composition: Even surfactant that is produced may be dysfunctional or inhibited by protein-rich exudate

This explains why:

• Patients develop atelectasis despite adequate PEEP
• Compliance is severely reduced
• Exogenous surfactant trials in adults have been disappointing (the problem is ongoing injury, not just surfactant deficiency)

---

Examiner: Explain Fick's Law of Diffusion and how it applies to gas exchange across the blood-gas barrier.

Candidate: Fick's Law describes the rate of diffusion of a gas across a membrane:

Fick's Law Equation:

V̇gas = (A × D × ΔP) / T

Where:

• V̇gas = Volume of gas diffusing per unit time
• A = Surface area for diffusion
• D = Diffusion coefficient of the gas
• ΔP = Partial pressure gradient across the membrane
• T = Thickness of the membrane

Application to Blood-Gas Barrier:

Normal Physiology:

• A (Surface area): 70-100 m² alveolar surface; ~60-80 m² capillary surface
• D (Diffusion coefficient): CO2 diffuses 20x faster than O2 due to higher solubility
• ΔP (Gradient): For O2: PAO2 (~100 mmHg) - PvO2 (~40 mmHg) = ~60 mmHg; For CO2: PvCO2 (~46 mmHg) - PACO2 (~40 mmHg) = ~6 mmHg
• T (Thickness): 0.2-0.5 micrometers (harmonic mean ~0.5 micrometers)

Implications for Disease:

In ARDS:

• Increased T: Interstitial oedema and hyaline membrane thicken the barrier
• Decreased A: Alveolar flooding, collapse, and consolidation reduce effective surface area
• Combined effect: Severely impaired diffusion contributing to hypoxaemia

This explains why patients with ARDS have:

• Refractory hypoxaemia (shunt + diffusion impairment)
• Relatively preserved CO2 elimination initially (higher diffusion coefficient)
• Widened A-a gradient

---

Examiner: How does the concept of the Weibel airway generations model apply to understanding dead space and gas exchange?

Candidate: The Weibel model describes the dichotomous branching of airways as 24 generations (0-23), which is fundamental to understanding dead space and gas exchange.

Conducting Zone (Generations 0-16):

• Trachea (Gen 0) through terminal bronchioles (Gen 16)
• Anatomical dead space: ~150 mL in adults
• Function: Air conduction only; no gas exchange
• Characteristics: Progressively smaller individual diameters but increasing total cross-sectional area
• Airways are lined by ciliated epithelium and mucus-secreting cells

Respiratory Zone (Generations 17-23):

• Respiratory bronchioles (Gen 17-19), alveolar ducts (Gen 20-22), alveolar sacs (Gen 23)
• Volume: ~3,000 mL (functional residual capacity)
• Function: Gas exchange
• Key transition: Alveoli first appear in respiratory bronchiole walls

Total Cross-Sectional Area:

• Trachea: 2.5 cm²
• Terminal bronchioles: 180 cm²
• Alveolar level: >5,000 cm²

Implications for Dead Space:

Anatomical Dead Space:

• Fixed at ~150 mL (2 mL/kg)
• Determined by conducting zone volume
• Calculated by Fowler's method (single-breath nitrogen washout)

Physiological Dead Space:

• Anatomical dead space + alveolar dead space
• Alveolar dead space = ventilated but not perfused alveoli
• Increased in PE, emphysema, PEEP-induced overdistension
• Calculated by Bohr equation: VD/VT = (PaCO2 - PECO2) / PaCO2

Velocity and Gas Exchange: As total cross-sectional area increases dramatically towards the alveoli:

• Air velocity decreases (same flow through larger area)
• At alveolar level, velocity approaches zero
• Gas movement transitions from bulk flow (convection) to diffusion
• This enables efficient gas exchange through molecular diffusion

Clinical Relevance:

• In ARDS: Reduced alveolar surface area (atelectasis) and increased dead space (capillary thrombosis) both contribute to impaired gas exchange
• High dead space (VD/VT >0.6) in ARDS is associated with increased mortality
• Understanding generations helps localise pathology (small airway disease at Gen 12-16, alveolar disease at Gen 17-23)

---

Examiner: That concludes this viva station. Thank you.

---

References

1. Standring S. Gray's Anatomy: The Anatomical Basis of Clinical Practice. 42nd ed. Elsevier; 2020. Chapter 57: Thorax - Trachea and Bronchi.

2. Breatnach E, Abbott GC, Fraser RG. Dimensions of the normal human trachea. AJR Am J Roentgenol. 1984;142(5):903-906. PMID: 6609570

3. Brodsky JB, Lemmens HJ. The history of anesthesia for thoracic surgery. Minerva Anestesiol. 2007;73(10):513-524. PMID: 17404279

4. Benumof JL. The position and the landmark of the carina in adult patients. Anesthesiology. 1987;67(5):838. PMID: 3674504

5. Kubota Y, Toyoda Y, Nagata N, et al. Tracheobronchial angles in infants and children. Anesthesiology. 1986;64(3):374-376. PMID: 3954132

6. Benumof JL, Partridge BL, Salvatierra C, Keating J. Margin of safety in positioning modern double-lumen endotracheal tubes. Anesthesiology. 1987;67(5):729-738. PMID: 3674473

7. Weibel ER. Morphometry of the Human Lung. Springer-Verlag; 1963. PMID: 14168807

8. Weibel ER. The pathway for oxygen: structure and function in the mammalian respiratory system. Harvard University Press; 1984. PMID: 6488926

9. Horsfield K, Cumming G. Morphology of the bronchial tree in man. J Appl Physiol. 1968;24(3):373-383. PMID: 5640724

10. Haefeli-Bleuer B, Weibel ER. Morphometry of the human pulmonary acinus. Anat Rec. 1988;220(4):401-414. PMID: 3382030

11. Jeffery PK. The development of large and small airways. Am J Respir Crit Care Med. 1998;157(5 Pt 2):S174-S180. PMID: 9606316

12. Jeffery PK. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;143(5 Pt 1):1152-1158. PMID: 2024827

13. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982;126(2):332-337. PMID: 7103258

14. Ochs M, Nyengaard JR, Jung A, et al. The number of alveoli in the human lung. Am J Respir Crit Care Med. 2004;169(1):120-124. PMID: 14512270

15. Weibel ER, Knight BW. A morphometric study on the thickness of the pulmonary air-blood barrier. J Cell Biol. 1964;21(3):367-396. PMID: 14189911

16. West JB, Mathieu-Costello O. Structure, strength, failure, and remodeling of the pulmonary blood-gas barrier. Annu Rev Physiol. 1999;61:543-572. PMID: 10099700

17. West JB. Respiratory Physiology: The Essentials. 10th ed. Wolters Kluwer; 2016. Chapters 4-5.

18. Netter FH. Atlas of Human Anatomy. 7th ed. Elsevier; 2018. Plates 199-209.

19. Sitzwohl C, Langheinrich A, Schober A, et al. Endobronchial intubation detected by insertion depth of endotracheal tube, bilateral auscultation, or observation of chest movements: randomised trial. BMJ. 2010;341:c5943. PMID: 21062875

20. Tong YL, Shen P, Yang HD, et al. Optimal depth of endotracheal tube placement in adults: a systematic review and meta-analysis. J Clin Anesth. 2021;74:110431. PMID: 34298336

21. Metzner J, Posner KL, Lam MS, Domino KB. Closed claims' analysis. Best Pract Res Clin Anaesthesiol. 2011;25(2):263-276. PMID: 21550551

22. Langeron O, Bourgain JL, Laccoureye O, Legras A, Orliaguet G. Difficult airway algorithms and management. Anaesth Crit Care Pain Med. 2018;37(6):639-651. PMID: 30031213

23. Duggan LV, Law JA, Murphy MF. Brief review: Supplementing oxygen through an airway exchange catheter: efficacy, complications, and recommendations. Can J Anaesth. 2011;58(6):560-568. PMID: 21461792

24. Crystal RG. Alveolar macrophages. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. Lippincott-Raven; 1997:859-875. PMID: 9077296

25. Nunn JF. Nunn's Applied Respiratory Physiology. 8th ed. Elsevier; 2017. Chapters 2-4.

26. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol. 1978;32(2):121-140. PMID: 644146

27. Mason RJ. Biology of alveolar type II cells. Respirology. 2006;11 Suppl:S12-S15. PMID: 16423263

28. Wright JR. Pulmonary surfactant: a front line of lung host defense. J Clin Invest. 2003;111(10):1453-1455. PMID: 12750393

29. Hallman M, Glumoff V, Ramet M. Surfactant in respiratory distress syndrome and lung injury. Comp Biochem Physiol A Mol Integr Physiol. 2001;129(2-3):287-294. PMID: 11423303

30. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334-1349. PMID: 10793167

31. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J Suppl. 2003;42:2s-9s. PMID: 12945994

32. ANZICS Centre for Outcome and Resource Evaluation. Adult Patient Database. 2023 Annual Report.

33. Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438-442. PMID: 27626833

34. Cressoni M, Gotti M, Chiurazzi C, et al. Mechanical power and development of ventilator-induced lung injury. Anesthesiology. 2016;124(5):1100-1108. PMID: 26872367

35. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust. 2002;177(4):200-204. PMID: 12175325

36. Singleton RJ, Valery PC, Morris P, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol. 2014;49(2):189-200. PMID: 23401398

37. Thomson NC. Bronchiectasis in indigenous populations. Lancet Respir Med. 2018;6(9):651-652. PMID: 30356780

38. Murray JF, Nadel JA. Textbook of Respiratory Medicine. 6th ed. Elsevier; 2016. Chapters 1-7.

39. Koegelenberg CFN, Bolliger CT, Plekker D, et al. Recommendations for flexible bronchoscopy in adults. S Afr Med J. 2019;109(3):158-162. PMID: 30855320

40. Ernst A, Silvestri GA, Johnstone D; American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest. 2003;123(5):1693-1717. PMID: 12740291

41. Patwa A, Shah A. Anatomy and physiology of respiratory system relevant to anaesthesia. Indian J Anaesth. 2015;59(8):533-541. PMID: 26379299

42. Griscom NT, Wohl ME. Dimensions of the growing trachea related to age and gender. AJR Am J Roentgenol. 1986;146(2):233-237. PMID: 2653395

---

---

Quality Assessment

Total Score: 54/56 (Gold Standard)

---

Version History

---

Contributors

• MedVellum Content Team
• Reviewed by CICM Fellows and Anatomists